— Know what they know.
Not Investment Advice

OM NASDAQ

Outset Medical, Inc.
1W: +29.8% 1M: +7.9% 3M: -22.1% YTD: +7.0% 1Y: -71.8% 3Y: -97.6% 5Y: -99.5%
$3.96
+0.21 (+5.60%)
 
Weekly Expected Move ±14.3%
$3 $3 $4 $5 $5
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 51 · $73.4M mcap · 15M float · 1.20% daily turnover · Short 46% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$73.4M
52W Range2.84-16.16
Volume483,406
Avg Volume186,711
Beta1.90
Dividend—
Analyst Ratings
7 Buy 3 Hold 1 Sell
Consensus Buy
Company Info
CEOLeslie L. Trigg
Employees310
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-09-15
3052 Orchard Drive
San Jose, CA 95134
US
669 231 8200
About Outset Medical, Inc.

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

Recent Insider Trades

NameTypeSharesPriceDate
Brottem John L. S-Sale 2,632 $4.39 2026-08-17
Gaeta Renee S-Sale 4,543 $4.39 2026-08-17
Trigg Leslie S-Sale 3,437 $4.39 2026-08-17
Gaeta Renee A-Award 71,630 — 2026-06-26
Trigg Leslie A-Award 99,160 — 2026-06-26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms